AXIM BIOTECHNOLOGIES, INC. (AXIM) › Net IncomeAXIM BIOTECHNOLOGIES, INC. (AXIM) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$2.8K2012: -$14.9K2013: -$89.2K2014: -$582.9K2015: -$10.09M2016: -$5.81M2017: -$4.17M2018: -$6.75M2019: -$6.45M2020: -$6.41M2021: -$16.03M2022: -$6.24M2023: -$8.06M-$8.06M2011Net Income (USD)2023Fiscal YearNet IncomeChange YoY2023-$8.06M-29.1%2022-$6.24M+61.1%2021-$16.03M-150.1%2020-$6.41M+0.6%2019-$6.45M+4.5%2018-$6.75M-62.1%2017-$4.17M+28.3%2016-$5.81M+42.4%2015-$10.09M-1631.3%2014-$582.9K-553.4%2013-$89.2K-498.6%2012-$14.9K-433.4%2011-$2.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share